Showing results (71-80 of 145) with videos related to
Sort By:
Pageof 15
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospitalJavier Salvador, Cristina Grávalos, Joan Albanell, et al.JTO Clinical and Research Reports|June 19, 2025
Erratum to 'Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815]Federico Cappuzzo, Zanete Zvirbule, Ernesto Korbenfeld, et al.JTO Clinical and Research Reports|April 18, 2025
Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLCFederico Cappuzzo, Zanete Zvirbule, Ernesto Korbenfeld, et al.Frontiers in Oncology|October 29, 2020
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy EfficacyMaitane Ocáriz-Díez, Mara Cruellas, Marta Gascón, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the adjuvant treatment of colorectal cancerCristina Grávalos Castro, Joan Maurel Santasusana, Fernando Rivera Herrero, et al.Eclinicalmedicine|July 1, 2021
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trialGlenwood D Goss, Manuel Cobo, Shun Lu, et al.Infection and Immunity|February 2, 2021
How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A ReviewMara Cruellas, Alfonso Yubero, María Zapata, et al.Journal of Medical Economics|October 10, 2024
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysisDolores Isla, Rosa Álvarez, María Arnal, et al.Clinical Lung Cancer|December 3, 2016
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by SurgeryMariacarmela Santarpia, Jose Luis Ramirez, Itziar de Aguirre, et al.BMC Psychology|November 24, 2020
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal studyN Nuria Viñolas, Rosario Garcia-Campelo, Margarita Majem, et al.Pageof 15